Browse by Author Sheung, TF

TitleAuthor(s)YearView Count
An Akt/hypoxia-inducible factor-1α/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cellsChi, KL; Zhen, FY; Ho, DW; Ng, MN; Yeoh, GCT; Poon, RTP; Sheung, TF2009183
The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinomaShen, Z; Zhen, FY; Gao, Y; Ji, CL; Hai, XC; Ching, CL; Poon, RTP; Sheung, TF; Luk, JM; Kong, HS; Tsai, PL; Ren, BG; Ming, LH; Hsiang, FK; Lin, MCM2008147
Identification of local and circulating cancer stem cells in human liver cancerZhen, FY; Ngai, P; Ho, DW; Wan, CY; Ng, MNP; Chi, KL; Li, MLY; Ka, HT; Chi, TL; Poon, RTP; Sheung, TF2008124
Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: Implications for salvage liver transplantNg, KK; Chung, ML; Chi, LL; Poon, RTP; See, CC; Sheung, TF2008138
Pancreatic-induced intramural duodenal haematomaMa, JK; Ng, KKC; Poon, RT; Sheung, TF200874
Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinomaHo, JC; Ying, CI; Siu, TC; Yuk, TL; Kui, FC; San, YW; Sheung, TF2008128
Management of carcinoma of the gallbladder: A single-institution experience in 16 yearsSiu, YC; Poon, RTP; Chung, ML; Ng, K; Sheung, TF200879
A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: Implication for patient selection in systemic therapy trialsYau, T; Tzy, JY; Chan, P; Ng, K; Sheung, TF; Poon, RTP2008131
Tumor size and operative risks of extended right-sided hepatic resection for hepatocellular carcinoma: Implication for preoperative portal vein embolizationChik, BH; Chi, LL; Sheung, TF; Chung, ML; Poon, RTP; Chi, ML; Wong, J2007104
Distinct pathways of genomic progression to benign and malignant tumors of the liverTward, AD; Jones, KD; Yant, S; Siu, TC; Sheung, TF; Chen, X; Kay, MA; Wang, R; Bishop, JM2007167
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinomaChi, KL; Zhen, FY; Shuk, PL; Chi, TL; Ngai, P; Ka, HT; Poon, RTP; Sheung, TF2007174
Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinomaKhan, MR; Poon, RTP; Ng, KK; Chan, AC; Yuen, J; Tung, H; Tsang, J; Sheung, TF2007135
Traditional Chinese herbalmedicines for treatmentof liver¢brosis and cancer: fromlaboratorydiscovery to clinical evaluationLuk, JM; Wang, XL; Liu, P; Wong, KF; Chan, KL; Tong, Y; Hui, CK; Lau, GK; Sheung, TF200796
Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cellsYing, CI; Siu, TC; Yuk, TL; Ho, JC; Sheung, TF200796
Significance of circulating endothelial progenitor cells in hepatocellular carcinomaHo, JWY; Pang, RWC; Lau, C; Sun, CK; Wan, CY; Sheung, TF; Poon, RTP2006113
Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: Dual roles in antiapoptosis and cell repairHo, DW; Zhen, FY; Chi, KL; Ka, HT; To, JY; Poon, RT; Sheung, TF200678
Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolizationChok, KS; Ng, KK; Poon, RTP; Chi, ML; Yuen, J; Wai, KT; Sheung, TF2006109
Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinomaXiao, QW; Luk, JM; GarciaBarcelo, M; Miao, X; Leung, PP; Ho, DW; Siu, TC; Lam, BY; Cheung, CK; Wong, AS; Lau, SS; Man, TS; Wan, CY; Cai, Q; Liu, KS; Chee, KH; Lau, GK; Poon, RTP; Wong, J; Sheung, TF2006126
Preoperative plasma transcript AA454543 level is an independent prognostic factor for hepatocellular carcinoma after partial hepatectomySiu, TC; Chi, LL; Chow, JPH; Yuk, TL; Ying, CI; Ho, JCY; Sheung, TF2006115
Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expressionLee, TK; Poon, RTP; Yuen, AP; Man, K; Zhen, FY; Xin, YG; Sheung, TF2006152